Novo Nordisk’s blockbuster GLP-1 products Ozempic and Wegovy are among the next 15 drugs subject to the government’s Medicare ...

FDA approves AstraZeneca's Calquence as first BTK inhibitor for first-line mantle cell lymphoma, leading BeiGene's Brukinsa ...

Spark co-founder Kathy High made a quiet return to eye disease drug development, becoming CEO of US-Swiss biotech RhyGaze ...

FDA approves Amgen's Lumakras with Vectibix for metastatic colorectal cancer with KRAS G12C mutation, based on Phase 3 ...

The rise of GLP-1s have made treating obesity one of the largest market opportunities in history. It also has reinforced a ...

Teva is the latest drugmaker to file suit against Medicare negotiations. But unlike other companies that have challenged the ...

The EMA's human medicines committee recommended 114 medicines for approval in 2024, marking the highest number of positive ...

After seeing its Covid-19 drug fail in a Phase 3 trial last year, Shionogi on Thursday won a $375 million award from HHS to ...

HHS told the Second Circuit that Boehringer Ingelheim’s voluntary participation in Medicare negotiations “undermines” its ...

UnitedHealth CEO Witty addresses healthcare issues post Brian Thompson's killing, emphasizes existing solutions and defends ...

Most clinical trials for Huntington’s disease have run aground in the last few years, but academic researchers haven’t been ...

US regulators have rejected a T cell therapy for a rare and serious transplant complication related to Epstein-Barr virus ...